![](/img/cover-not-exists.png)
A pilot study of ruxolitinib as a front-line therapy for 12 children with secondary hemophagocytic lymphohistiocytosis
Zhang, Qing, Wei, Ang, Ma, Hong-Hao, Zhang, Li, Lian, Hong-Yun, Wang, Dong, Zhao, Yun-Ze, Cui, Lei, Li, Wei-Jing, Yang, Ying, Wang, Tian-You, Li, Zhi-Gang, Zhang, RuiJournal:
Haematologica
DOI:
10.3324/haematol.2020.253781
Date:
July, 2020
File:
PDF, 1.05 MB
2020